Hospital‑acquired pneumonia increases the length of in-patient hospital stay and is associated with high mortality rates, particularly in older people. Pharmacists and healthcare professionals need to know how to diagnose and manage the condition, and be cognisant of the gaps in the evidence base.
Stroke: classification and diagnosisSubscription
In light of the many pressures currently facing the NHS, as well as an ever increasing ageing population, pharmacists and healthcare professionals should be aware of the risk factors for stroke, its classification and diagnosis.
Bronchiectasis is a common chronic disease where the airways of the lungs become abnormally widened. Patients present with recurrent cough, sputum production and are at risk of respiratory tract infections. Pharmacists and healthcare professionals need to be aware of the latest management strategies.
Pharmacogenomics: an overviewSubscription
With the NHS working towards the integration of personalised medicine, in particular, aiming for whole-genome sequencing to be standard for specific conditions by 2020, it is important for pharmacists and healthcare professionals to be aware of the principles of pharmacogenomics and its evolving application into clinical practice.
Diabetes in pregnancy is associated with risks to the woman and to the developing foetus. Pharmacists and healthcare professionals need to be able to support and educate women who are planning pregnancy and those who are already pregnant to manage their diabetes.
The diabetic footSubscription
Diabetes-related foot problems are common, and negatively impact patients’ quality of life, so it is important that pharmacists are aware of symptoms and the relevant care pathways for these patients to ensure they receive the best care and education regarding how to manage their condition. Produced in partnership with RB.
Non-alcoholic fatty liver disease is the term for a range of conditions caused by a build-up of fat in the liver. The condition is thought to be highly prevalent; however, the dearth of symptoms during early disease and the lack of a specific diagnostic test make it difficult to detect and manage at an early stage. This presents a considerable challenge for healthcare professionals.
Heparin is widely used for thromboprophylaxis or as a treatment in many clinical situations, however, it can cause serious adverse effects. Heparin-induced thrombocytopenia (HIT), an immune-mediated adverse drug reaction, is associated with high morbidity and mortality if undiagnosed.
Early diagnosis of lower limb oedema is crucial to prevent early oedema becoming chronic. Pharmacists and other healthcare professionals are ideally placed to identify patients on certain medicines at higher risk of oedema, and should be aware of signs of chronic oedema when assessing patients to allow for prompt referral.
Fluoroquinolones for treating tuberculosisSubscription
Tuberculosis (TB) remains a significant global health and socioeconomic challenge. The duration of current anti-TB therapies, the adverse effects of certain anti-TB drugs and the growing problem of drug-resistant TB on an international scale mean that it is imperative for new, effective and safe treatment regimens to be developed. Fluoroquinolones are a class of drugs that have been used in the treatment of TB for several decades. This article provides an overview of the current treatment ...
Depression in adults: recognition and managementSubscription
Pharmacists and healthcare professionals should be able to recognise the symptoms of depression in people who use their services and direct them towards accessing treatment. This article examines how a diagnosis of depression is made, the pharmacological and non-pharmacological treatments available, specific considerations for different patient groups, self-management approaches, and the role of the pharmacy team in managing and supporting patients who have symptoms of depression.
Multiple myeloma: pharmacological managementSubscription
Although multiple myeloma is currently regarded as being incurable in the majority of patients, the outlook for patients diagnosed with the condition has improved markedly over the last 40 years, with survival rates quadrupling. Significant advances in both treatment and supportive therapies have contributed to these improved outcomes and are discussed in this article.
CLUSTER 1. Expert Professional Practice
CLUSTER 2. Collaborative Working Relationships
CLUSTER 1. Patient and Pharmaceutical Care
CLUSTER 2. Professional Practice Competencies
CLUSTER 3. Personal Practice Competencies
CLUSTER 4: Management and organisation